06118.HK
Austar Lifesciences Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 0.52
−0.95%Year over year
Reported trailing growth
- Revenue
- +9.7%
- EBITDA
- -12.0%
- EBIT
- -49.4%
- EPS
- -51.2%
- Free cash flow
- +35.5%
- Operating cash flow
- +57.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.8%
- EBITDA
- -16.7%
- EBIT
- -22.5%
- Net income
- -27.2%
- EPS
- -27.0%
- Free cash flow
- +27.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026